Skip to content
← Full study record

NCT00453206 · MORE INFO

Limitations, agreements, and source contact

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases · Source last updated 2018-09-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
By the time the primary objective of this trial was completed, the treatment approach of the trial had become standard of care. Analysis was therefore limited.
point Of Contact
email
dhurd@wakehealth.edu
organization
Wake Forest University Health Sciences
phone
336-716-2843
title
David Hurd, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
By the time the primary objective of this trial was completed, the treatment approach of the trial had become standard of care. Analysis was therefore limited.
point Of Contact
email
dhurd@wakehealth.edu
organization
Wake Forest University Health Sciences
phone
336-716-2843
title
David Hurd, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice